News Beyond Our Pages
Authors: Marc E. Rothenberg, Harold S. Nelson
Journal: Journal of Allergy and Clinical Immunology (2009)

Exhaled nitric oxide (eNO) and management of childhood asthmaIn a trial in 151 children with asthma, de Jongste et al (Am J Respir Crit Care Med 2009;179:93-7) compared management using daily asthma symptoms with management using daily asthma symptoms plus daily measurement of eNO. Inhaled corticosteroid doses were adjusted every 3 weeks throughout the study. After 30 weeks, there was no difference between the 2 strategies in the primary outcome of symptom-free days. The results are consistent with previous trials in children in which inclusion of eNO monitoring failed to improve asthma management.All rhinoviruses sequencedThe good, the bad, the vitamin EView Large Image Figure ViewerDownload Hi-res image Download (PPT)“[The two] isoforms have opposing functions”Joan Cook-MillsView Large Image Figure ViewerDownload Hi-res image Download (PPT)Redefining the role of eosinophils in asthmaView Large Image Figure ViewerDownload Hi-res image Download (PPT)Parameswaran NairView Large Image Figure ViewerDownload Hi-res image Download (PPT)“These articles provide ample evidence that eosinophils are indeed key effector cells in human asthma (at least in some patient subgroups) and should reignite the eosinophil as a target for asthma.”—Dr. Marc E. RothenbergIan PavordView Large Image Figure ViewerDownload Hi-res image Download (PPT)News items are written by Sherri Gabbert, PhD.Have you read an article that you think JACI readers would be interested in? Send your suggestions to the News Beyond Our Pages at [email protected] . Exhaled nitric oxide (eNO) and management of childhood asthmaIn a trial in 151 children with asthma, de Jongste et al (Am J Respir Crit Care Med 2009;179:93-7) compared management using daily asthma symptoms with management using daily asthma symptoms plus daily measurement of eNO. Inhaled corticosteroid doses were adjusted every 3 weeks throughout the study. After 30 weeks, there was no difference between the 2 strategies in the primary outcome of symptom-free days. The results are consistent with previous trials in children in which inclusion of eNO monitoring failed to improve asthma management. In a trial in 151 children with asthma, de Jongste et al (Am J Respir Crit Care Med 2009;179:93-7) compared management using daily asthma symptoms with management using daily asthma symptoms plus daily measurement of eNO. Inhaled corticosteroid doses were adjusted every 3 weeks throughout the study. After 30 weeks, there was no difference between the 2 strategies in the primary outcome of symptom-free days. The results are consistent with previous trials in children in which inclusion of eNO monitoring failed to improve asthma management. All rhinoviruses sequenced The good, the bad, the vitamin E“[The two] isoforms have opposing functions”Joan Cook-MillsView Large Image Figure ViewerDownload Hi-res image Download (PPT) “[The two] isoforms have opposing functions” “[The two] isoforms have opposing functions” Redefining the role of eosinophils in asthmaParameswaran NairView Large Image Figure ViewerDownload Hi-res image Download (PPT)“These articles provide ample evidence that eosinophils are indeed key effector cells in human asthma (at least in some patient subgroups) and should reignite the eosinophil as a target for asthma.”—Dr. Marc E. RothenbergIan PavordView Large Image Figure ViewerDownload Hi-res image Download (PPT)News items are written by Sherri Gabbert, PhD.Have you read an article that you think JACI readers would be interested in? Send your suggestions to the News Beyond Our Pages at [email protected] . “These articles provide ample evidence that eosinophils are indeed key effector cells in human asthma (at least in some patient subgroups) and should reignite the eosinophil as a target for asthma.”—Dr. Marc E. Rothenberg “These articles provide ample evidence that eosinophils are indeed key effector cells in human asthma (at least in some patient subgroups) and should reignite the eosinophil as a target for asthma.” —Dr. Marc E. Rothenberg News items are written by Sherri Gabbert, PhD.Have you read an article that you think JACI readers would be interested in? Send your suggestions to the News Beyond Our Pages at [email protected] . Have you read an article that you think JACI readers would be interested in? Send your suggestions to the News Beyond Our Pages at [email protected] . Have you read an article that you think JACI readers would be interested in? Send your suggestions to the News Beyond Our Pages at [email protected] .